0	7	Genomic	genomic	JJ
8	20	organization	organization	NN
20	21	,	,	,
22	30	sequence	sequence	NN
30	31	,	,	,
32	35	and	and	CC
36	51	transcriptional	transcriptional	JJ
52	62	regulation	regulation	NN
63	65	of	of	IN
66	69	the	the	DT
70	75	human	human	JJ
76	83	eotaxin	eotaxin	NN
84	88	gene	gene	NN
88	89	.	.	.

91	98	Eotaxin	Eotaxin	NNP
99	101	is	be	VBZ
102	104	an	an	DT
105	115	eosinophil	eosinophil	NN
116	124	specific	specific	JJ
125	139	beta-chemokine	beta-chemokine	NN
140	147	assumed	assume	VBN
148	150	to	to	TO
151	153	be	be	VB
154	162	involved	involve	VBN
163	165	in	in	IN
166	178	eosinophilic	eosinophilic	JJ
179	191	inflammatory	inflammatory	JJ
192	200	diseases	disease	NNS
201	205	such	such	JJ
206	208	as	as	IN
209	215	atopic	atopic	JJ
216	226	dermatitis	dermatitis	NN
226	227	,	,	,
228	236	allergic	allergic	JJ
237	245	rhinitis	rhinitis	NN
245	246	,	,	,
247	253	asthma	asthma	NN
254	257	and	and	CC
258	267	parasitic	parasitic	JJ
268	278	infections	infection	NNS
278	279	.	.	.

280	283	Its	its	PRP$
284	294	expression	expression	NN
295	297	is	be	VBZ
298	307	stimulus-	stimulus-	NN
308	311	and	and	CC
312	325	cell-specific	cell-specific	JJ
325	326	.	.	.

327	329	We	we	PRP
330	334	here	here	RB
335	343	describe	describe	VBP
344	347	the	the	DT
348	355	genomic	genomic	JJ
356	368	organisation	organisation	NN
369	370	(	(	(
370	371	3	3	CD
372	377	exons	exon	NNS
378	380	of	of	IN
381	384	132	132	CD
384	385	,	,	,
386	389	112	112	CD
390	393	and	and	CC
394	397	542	542	CD
398	400	bp	bp	NN
401	404	and	and	CC
405	406	2	2	CD
407	414	introns	intron	NNS
415	417	of	of	IN
418	422	1211	1211	CD
423	426	and	and	CC
427	430	378	378	CD
431	433	bp	bp	NN
433	434	)	)	)
435	438	and	and	CC
439	447	sequence	sequence	NN
448	457	including	include	VBG
458	459	3	3	CD
460	462	kb	kb	NN
463	465	of	of	IN
466	469	DNA	dna	NN
470	474	from	from	IN
475	478	the	the	DT
479	488	immediate	immediate	JJ
489	490	5	5	CD
490	491	’	'	SYM
492	500	upstream	upstream	JJ
501	507	region	region	NN
508	510	of	of	IN
511	514	the	the	DT
515	520	human	human	JJ
521	528	eotaxin	eotaxin	NN
529	533	gene	gene	NN
533	534	.	.	.

535	540	Among	among	IN
541	544	the	the	DT
545	555	regulatory	regulatory	JJ
556	564	promoter	promoter	NN
565	573	elements	element	NNS
574	585	potentially	potentially	RB
586	596	regulating	regulate	VBG
597	604	eotaxin	eotaxin	NN
605	609	gene	gene	NN
610	620	expression	expression	NN
621	627	and/or	and/or	CC
628	637	mediating	mediate	VBG
638	641	the	the	DT
642	649	effects	effect	NNS
650	652	of	of	IN
653	670	anti-inflammatory	anti-inflammatory	JJ
671	676	drugs	drug	NNS
677	679	we	we	PRP
680	690	identified	identify	VBD
691	700	consensus	consensus	NN
701	710	sequences	sequence	NNS
711	716	known	know	VBN
717	719	to	to	TO
720	728	interact	interact	VB
729	733	with	with	IN
734	741	nuclear	nuclear	JJ
742	749	factors	factor	NNS
750	754	like	like	IN
755	761	NF-IL6	NF-IL6	NNP
761	762	,	,	,
763	767	AP-1	AP-1	NNP
767	768	,	,	,
769	770	a	a	DT
771	781	NF-kappa-B	nf-kappa-b	NN
782	786	like	like	IN
787	796	consensus	consensus	NN
797	805	sequence	sequence	NN
806	809	and	and	CC
810	827	gamma-interferon-	gamma-interferon-	NN
828	830	as	as	RB
831	835	well	well	RB
836	838	as	as	IN
839	853	glucocorticoid	glucocorticoid	NN
854	862	response	response	NN
863	871	elements	element	NNS
871	872	.	.	.